The sciences of medical care, medical teaching and bioresearch at University of California, Los Angeles have received a boost in the form of an unrestricted gift of $50 million. Given to the David Geffen School of Medicine at UCLA from the estate of Irma and Norman Switzer, the gift was announced Nov. 12 at a gathering of faculty, staff members, the school’s board of visitors and friends of the Switzer family.Read More
Science Market Update
The UC San Francisco Medical Center is home to some of nation’s best doctors, industry-leading bio-researchers, and most recently, an angel. UCSF is proudly unveiling a new outpatient medical building- thanks to a $40 million gift from “angel investor” and philanthropist Ron Conway and his family.Read More
When life gives you lemons, make lemonade… and if you’ve got lemonade, make a lemonade stand. However, when Alex’s Lemonade Stand Foundation gives you millions in research funding, now you can help cure childhood cancer. Thanks to a little girl who once made lemonade to raise money for childhood cancer research, two UC San Francisco faculty members are among researchers being nationally acknowledged for their work in pediatric oncology.Read More
Tags: CA, Bioresearch funding, Leukemia, California, Pediatric Cancer Research, grants, 2015, Biotechnology, Life Science, UCSF, San Francisco at Mission Bay, cancer research funding, Biotechnology Vendor Showcase Event
The University of California, San Diego is one of only five public universities in the U.S. to make the top 20 list in a new ranking of the world’s top 500 colleges. The campus took the No. 18 spot in U.S. News and World Report’s first-ever global ranking of universities which measured factors such as research, global and regional reputation, international collaboration as well as number of highly-cited papers and doctorates awarded. And with unending support and grants flowing in, UC San Diego is able to invest in the latest cutting edge tools for this world class research.Read More
There are thousands of genes in the human genome that all have different purposes. At least 3,000 of these genes are known to express proteins that can be altered by different medications, however, the FDA has only approved drugs that target around 10 percent of these genes. That means that there are still thousands of genes that have not been thoroughly studied that, with the help of the right medication, could be targeted to help improve human health. The National Institutes of Health Common Fund has awarded 8 U.S. institutions $5.8 million for a new collaborative three-year program called Illuminating the Druggable Genome (IDG) that will study different genes and their potential to be modified by different medicines.Read More
Tags: CA, Mount Sinai School of Medicine, University of California San Francisco, Texas Medical Center, New York, Southwest, 2015, MSSM, tmc, San Francisco, SFVS, BioResearch Product Faire Event, Houston, NY, TX, UC San Francisco, Biotechnology Vendor Showcase Event, North East
Are you a laboratory supplier who is looking to expand your presence in the Southern California area and increase your influence at the top California Universities?
The NIH has just announced $5.3M in two new awards through the Autism Centers of Excellence (ACE) program to support autism research studies led by two University of California investigative teams, at UCLA and the UC Davis Medical Center MIND Institute. ACE funding is earmarked for large, multi-disciplinary studies into the origins of autism spectrum neurological disorders and avenues for their treatment. In the case of the two latest awardees, one is a clinical behavioral study and one is a study of genetic variants. The $5.3M is initial one-year funding, with extensions of up to five years. The ACE program includes both centers and networks. Centers are made up of multiple investigators at one site working together on a specific research problem; networks include investigative teams from different sites engaged in a focused study. Both UCLA and UC Davis are ACE centers and will lead the current research projects, though in collaboration with colleagues at other research institutions, namely Harvard, UW, Vanderbilt, Emory, Johns Hopkins, and Yale. As with all ACE research, data and findings are collected centrally by the NIH to maximize their availability to the larger research community.
Tags: 2014, CA, 2013, Southwest, Los Angeles, Autism, LAVS, UCDMC, BioResearch Product Faire Event, Funding, UCLA, Genetics, Research, Sacramento, Davis, NIH funding, UC Los Angeles, UC Davis, Biotechnology Vendor Showcase Event
Following up on our much-read April 2011 blog on Biomedical Building News at UCSD, we are pleased to report that the following UCSD medical facilities have celebrated their grand openings:
Tags: CA, biomedical research, Stem cell research, New research facilities, new science wet labs, Southwest, 2012, San Diego, SDVS, Genomics, UC San Diego, LEED, Biotechnology Vendor Showcase Event, 2011
Cows get pneumonia, or bovine respiratory disease, and it kills more than a million of them each year, making BRD the leading cause of (accidental) death for beef and dairy cattle. That translates to a loss of about $692 Million annually. To combat this loss, the USDA has just invested $9.75 Million in a 5-year project to come up with genomic and management approaches to the BRD problem.